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Abstract
Background: Negative regulators of signal transduction cascades play critical roles in controlling different aspects
of normal embryonic development. Sprouty2 (Spry2) negatively regulates receptor tyrosine kinases (RTK) and FGF
signalling and is important in differentiation, cell migration and proliferation. In vertebrate embryos, Spry2 is
expressed in paraxial mesoderm and in forming somites. Expression is maintained in the myotome until late stages
of somite differentiation. However, its role and mode of action during somite myogenesis is still unclear.
Results: Here, we analysed chick Spry2 expression and showed that it overlaps with that of myogenic regulatory
factors MyoD and Mgn. Targeted mis-expression of Spry2 led to inhibition of myogenesis, whilst its C-terminal
domain led to an increased number of myogenic cells by stimulating cell proliferation.
Conclusions: Spry2 is expressed in somite myotomes and its expression overlaps with myogenic regulatory factors.
Overexpression and dominant-negative interference showed that Spry2 plays a crucial role in regulating chick
myogenesis by fine tuning of FGF signaling through a negative feedback loop. We also propose that mir-23, mir-27
and mir-128 could be part of the negative feedback loop mechanism. Our analysis is the first to shed some light
on in vivo Spry2 function during chick somite myogenesis.
Background
In early vertebrate embryos, including the chick, somites
form as paired structures from unsegmented paraxial
mesoderm on either side of the neural tube. Cells in the
ventral somite undergo an epithelial to mesenchymal tran-
sition (EMT) to form the sclerotome [1]. The dorsal part
remains epithelial forming the dermomyotome, which
generates the epaxial and hypaxial domains of the myo-
tome. The dermomyotome gives rise to the dermis and
skeletal musculature whilst the sclerotome mainly gives
rise to the ribs [2]. A network of signalling pathways and
transcription factors coordinates the process of somite
patterning and differentiation and how the myogenic pro-
gramme in particular is activated differs in different parts
of the body [3]. Sonic hedgehog (Shh) from the notochord
and floor plate together with neural tube derived Wnt sig-
nals specify the epaxial dermomyotome which is impor-
tant for generating the axial back muscles [4-6]. Wnt
signals from the dorsal ectoderm and bone morphogenetic
protein (BMP) signals from the lateral plate mesoderm
promote formation of the hypaxial myotome, which
generates the limb, diaphragm and body wall muscles [7].
Fibroblast growth factors (FGF) and extracellular signal-
regulated kinases/mitogen-activated protein kinases (ERK/
MAPK) have been found to be crucial during somite
formation and in regulating limb myogenesis [8,9].
Downstream of FGF are Sprouty proteins, cytoplasmic
membrane-associated proteins, which function by inhibit-
ing receptor tyrosine kinase (RTK) signalling (reviewed in
[10]). Sprouty was first identified in Drosophila by genetic
screens as an antagonist of the FGF receptor Breathless
during tracheal branching [11].
To date, four mammalian homologs of Drosophila
Sprouty have been identified (Spry1-4). They encode
32 to 34 kDa proteins that share a highly conserved
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carboxy-terminal cysteine-rich Sprouty domain and were
shown to function as negative regulators of RTK signal-
ling in vivo [12].
Sprouty transcripts showed highly restricted expres-
sion patterns during the morphogenesis of various
embryonic tissues including limbs [13], lung [14], inner
ear [15], kidney [16], testis [17], and tooth [18].
Functional studies implicate Sprouty proteins in the
control of proliferation, cell migration, tracheal branch-
ing and angiogenesis [11,13,19-23]. It has been reported
that human SPRY2 triggered migration and proliferation
of vascular smooth muscle cell and its expression
increased in rat carotid artery injury model. This was
associated with an inhibition of FGF signals and a
decrease of proliferation [24]. In a cancer mouse model,
loss of Spry2 function led to an increase in B-cell prolif-
eration due to hyperactivation of ERK/MAPK signalling
[23]. The expression of FGF target genes was enhanced
in palate of Spry2 knockout mice, and loss of Spry2 was
associated with an increase in palate mesenchymal cell
proliferation [25]. Recently, it has been shown that inhi-
biting Spry2 expression in renal cell carcinoma pro-
motes proliferation and invasion highlighting thus a
potential role for Spry2 during tumorigenesis [26].
We previously showed that chick Spry2 is expressed in
developing somites. In particular, its transcripts were
detected along the anterior and posterior somite edges
and in the centre of mature myotomes in a thin stripe
suggesting a possible function in secondary myogenesis
and myotome growth [9]. During limb bud develop-
ment, it has been reported that Spry2 and Spry1 are
expressed in muscles and tendons in both chick and
mouse. In Pax3 knockout mice Sprouty expression was
lost indicating that they are expressed in muscle pro-
genitors [27]. In addition, it has been shown, by using
artificial regeneration and rescue experiments in mouse,
that FGF6 and Spry2 are particularly involved in myo-
genesis [28]. Overexpression of SPRY2 in C2C12 cells in
presence of FGF2 led to induction of myogenesis whilst
inhibition of SPRY2 function led to myoblasts growth
and failure of myotube formation. These results were
the first evidence of Spry2 playing a role during myo-
genic differentiation in presence of FGF2 in vitro [29].
Here we investigated the role of Spry2 during somite
myogenesis. We examined the regulation of Spry2 in
response to FGF and we analysed its expression com-
pared to the myogenic markers MyoD and Mgn using
double in situ hybridisation. Functional interference
approaches utilized targeted mis-expression by electro-
poration showed that Spry2 inhibits somite myogenesis.
In contrast, inhibition of Spry2 function using its
C-terminal interference promoted somite myogenesis by
increasing proliferation of myogenic cells in the dermo-
myotome and myotome. Our results indicate that Spry2
regulates chick somite myogenesis through a negative
feedback loop to FGF2 and other factors including
microRNAs could be playing a role in this mechanism.
Results and discussion
Sprouty2 expression during somite myogenesis
Spry2 expression during somite development was analysed
at different Hamburger and Hamilton (HH) stages. At
stage HH11 expression was restricted to the pre-segmented
paraxial mesoderm (PSM) and in somites expression was
very weak (data not shown). Between HH20-HH27 expres-
sion was detected throughout the myotome and signal was
especially strong in the hypaxial domain (Figure 1A-Ai).
Frontal sections through the somites confirmed expression
in the myotome with increased signal strength at the
myotome boundaries at the junctions with the syndetome,
containing tendon progenitors (Figure 1Ai, Aii, arrow-
heads). In addition to its expression in somites, Spry2 was
expressed in both forelimb and hindlimb buds, in the
mesenchyme just beneath the apical ectodermal ridge and
in developing limb muscle (Figure 1A and Additional file
Figure S1A, Ai). Double in situ hybridisation with the
myogenic markers, MyoD and Mgn, showed clearly a high
degree of overlap (Figure 1B-Bii and Additional file Figure
S2A-Aiii).
We have previously detected Spry2 transcripts in
developing chick somites [9]. Here, we further analysed
these findings by co-localising Spry2 expression with
that of the early myogenesis markers MyoD and Mgn.
Our results are consistent with other previously
reported localisation of the mouse Spry2 transcripts in
the myotomes and dermomyotomes [27]. In addition, a
number of studies have also highlighted the involvement
of Spry1 and Spry2 proteins during the myogenic differ-
entiation [28,29].
Sprouty2 expression is regulated by FGF2
In many tissues the expression of Spry2 is activated by
FGFs and it acts in a negative feedback loop as an inhibi-
tor of FGF signalling (reviewed in [12]). To determine
whether FGF can regulate Spry2 in paraxial and lateral
plate mesoderm, we implanted beads soaked with FGF2
(400μg/ml) or FGF4 (50μg/ml) adjacent to forelimb or
hindlimb and flank level somites of HH16 embryos. PBS
beads were used as a control. Embryos were allowed to
develop for 24 hours and Spry2 expression was analysed
by in situ hybridization. In embryos implanted with FGF2
beads an ectopic limb bud was induced (Figure 2A, B,
arrowheads, 100%, n=15). This was associated with Spry2
expression in the distal tip of the ectopic limb bud, simi-
lar to the normal limb. In 50% of embryos we observed
an increase of Spry2 expression in the mesoderm close to
the bead (Figure 2A, arrowhead). Interestingly, when
FGF4 soaked beads (50μg/ml) were implanted similarly
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to FGF2, no ectopic limb buds or increased Spry2 was
detected (n=9)(Figure 2C, D). This may indicate that the
effect of FGF2 beads is specific, however we cannot
exclude the possibility that higher concentrations of
FGF4 may have the same effect. Control PBS beads did
not affect Spry2 expression (n=8) (Figure 2E, F).
It has been reported previously that Spry2, as well as
other related proteins such as Spred and Sef, are posi-
tively regulated by FGF signalling [30]. The first evidence
suggesting the involvement of FGF2 and Spry2 in myo-
genic differentiation through a negative feedback loop
was obtained in a well characterized cell based system
using C2C12 myoblasts [29]. However, in chick limb
mesenchyme, it has been reported that FGF4 rather than
FGF2 positively regulated Spry2 expression [27]. In the
context of neural development, Spry2 downregulation
resulted in upregulation of FGF2 and promoted axonal
elongation [31].
Targeted misexpression of Sprouty2 affects somite
myogenesis
Next we wanted to examine the role of Spry2 in somite
myogenesis using a gain-of-function and a functional
interference approach. First, we used microinjection and
electroporation of a plasmid encoding full length Spry2
and GFP from the same vector backbone (pCAB-Spry2-
IRES-GFP). Epithelial somites of HH16-17 embryos
were targeted. Embryos were harvested 24- or 48-hours
after electroporation after which transfected somites
were identified by GFP fluorescence and effects on myo-
genesis were examined by analysing changes in MyoD
expression using in situ hybridisation. This revealed a
loss of MyoD expression in regions of somite transfected
with pCAB-Spry2-IRES-GFP (n=19) (Figure 3A, Ai).
There was no difference in the effect of Spry2 misex-
pression on MyoD expression if electroporation was in
dermomyotomes or myotomes. Control embryos elec-
troporated with pCAB-IRES-GFP showed normal MyoD
expression (Figure 3B). We compared this phenotype to
that obtained with a different antagonist of FGF signal-
ling, which we had previously characterized [9]. We
electroporated expression constructs encoding Mkp3, a
dual-specific phosphatase, which inactivates ERK. Con-
sistent with previous observations the electroporation of
Mkp3-RFP led to localized loss of MyoD expression in
transfected somites (Figure 3C-Ci) (n=13, see also [9]).
Un-electroporated control embryos showed normal
MyoD expression (Figure 3D). Conversely, electropora-
tion of a truncated form of Spry2 which only contains
the carboxy-terminus, led to promotion of myogenesis
indicated by an increase in MyoD expression (n=27)
(Figure 4). This was detectable after 6 hours of electro-
poration (Figure 4A). Increased expression of MyoD was
also observed after 11, 24 and 48 hours (Figure 4B-Di).
We also noticed an increase in somite size after longer
incubation for 48 hours, when comparing electroporated
somites with those on the opposite side (Figure 4D, Di).
It has been previously shown that a Spry2 truncation,
which consists of only the C-terminal part, leads to loss
of Spry2 function [32]. It is still incompletely understood
how FGF signalling is regulated by its inhibitors during
early somite development. A number of FGF negative
regulators, among which is Spry2, have been identified
(reviewed in [33]). Here, the manipulations of Spry2
Figure 1 Expression of Spry2 in somites and limb buds is closely associated with MyoD. (A) Whole mount in situ hybridisation of chick
embryo at HH23 showing Spry2 expression in limb buds and somites, with strong signal visible in the hypaxial domains (arrowheads). (Ai)
Transverse section of embryo in (A) at the level of trunk somite showing Spry2 expression throughout the myotome with high levels in the
hypaxial domain (arrowheads). (Aii) Frontal section shows Spry2 expression in the myotomes, anterior and posterior myotome edges are
indicated by arrowheads. (B-Bii) Double in situ hybridisation detects Spry2 (purple, NBT/BCIP) and MyoD (red, Fast red) at HH24, (B) whole mount
chick embryo shows overlap in somites and limb bud, (Bi) transverse and (Bii) frontal sections show overlapping expression of Spry2 and MyoD.
Magnifications: 20x in (A), 200x in (Ai), 400x in (Aii & Bii), 22x in (B), 100x in (Bi).
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activity using gain-of-function and dominant-negative
interference suggest that it affects FGF signaling, potentially
activated by FGF2, through a negative feedback loop
mechanism. It has been shown in a considerable number of
other contexts that Spry2 regulates FGF signalling through
negative feedback. For example, this was demonstrated in
the developing limb bud and neural plate [30], sensory neu-
rons of dorsal root ganglia [31], 293 kidney cells [32], fibro-
blasts [34], brain [35], angiogenesis [36], neuritis in PC12
cells [37] and in Xenopus Spemann’s organizer [38].
Inhibition of Sprouty2 function increased the number of
mitotic cells in dermomyotomes and myotomes
As reported above, we observed that misexpression of
Spry2-Cterm caused increased MyoD expression. To
investigate the mechanism by which Spry2 induces this
effect and to determine whether this might be due to
increased proliferation of myogenic cells, we checked
MyoD expression and combined this with that of anti-
phospho-histone-H3 by immunostaining. We quantified
the number of mitotic cells 24 hours after electropora-
tion and compared microinjected somites with their
contralateral non-injected counterparts (n=94 paired
readings)(Figure 5A-B). The boundary of the dermo-
myotome, myotome and sclerotome in each section was
determined by staining with DAPI. We observed an
increase in the number of mitotic cells in the injected
dermomyotomes and myotomes (Figure 5B-Biii) com-
pared with that of the control side (Figure 5A-Aiii). This
suggests that cell proliferation is affected. The number
Figure 2 FGF2 activates ectopic Spry2 expression. (A, B) FGF2 beads implanted adjacent to flank level somites of HH16 embryos induced
outgrowth of an ectopic limb bud with Spry2 expression near the tip (arrowheads), Spry2 expression is expanded at the base of the forelimb (in
A, arrowhead) or hindlimb bud (in B) towards the bead. (C, D) FGF4 beads implanted adjacent to flank level somites of HH16 embryos do not
induce ectopic Spry2 expression. (E, F) PBS control beads implanted similarly to that of FGF2 and FGF4 at the level of the forelimb (E) or
hindlimb (F) flanks and show normal Spry2 expression. fl: Forelimb, hl: hindlimb. Magnifications: 18x in (A, B), 22x in (C, D, E), 24x in (F).
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of proliferating cells was analysed by the SSPS using
Wilcoxon test to determine whether the increase was
statistically significant or not. The analysis detected an
increase of 58% (P < 0.002) (Figure 5C).
Spry2 has been previously shown to regulate cellular
proliferation and migration in different biological sys-
tems [20,39]. Interference with Spry2 function by the C-
terminal part, which is a conserved domain in Droso-
phila, chick and mammals, was found to inhibit prolif-
eration and migration of HeLa cells indicating that
Spry2-C-terminus is important for its biological function
[20]. Similarly, we tested this function of Spry2 in the
myotomes and dermomyotomes using a Spry2 mutant
expression construct (pCAB-Spry2-Cterm) that contains
only the C-terminus. We observed a significant increase
in myocyte number after inhibiting Spry2 function, indi-
cating that it attenuates myogenic cell proliferation in
the forming somite.
In smooth muscle cells, wild type SPRY2 inhibits
migration and proliferation [24] and downregulation of
its function by mir-21 in cardiomyocytes, promotes pro-
liferation and cellular outgrowths [40]. Similarly, in
TGW neuroblastoma cells, a dominant negative form of
SPRY2 promoted cell proliferation [41] and depletion of
Spry2 expression in renal cell carcinoma led to
enhanced proliferation [26]. In Spry1-2 knockout mice,
it was reported that Spry2 promoted cellular prolifera-
tion and brain neurogenesis [42]. In addition to these
studies, it has been shown that loss of Spry2 function in
splenic B-cells resulted in an increase of phosphorylated
ERK1/2 activity and this was associated with an increase
in B cells proliferation [23]. Altogether, these studies
suggested that Spry2 functions to regulate FGF/ERK-
MAPK siganlling during cellular proliferation through a
negative feedback loop. This notion in general is consis-
tent with our results since in our experiments interfer-
ence with Spry2 function led similarily to an increase in
the myocyte cell number. Additional antagonists of the
FGF/ERK-MAPK signalling include the dual specificity
phosphatase PYSTI/Mkp3, which similar to Spry2, initi-
ates a negative feedback loop found to be important
during limb bud outgrowth and neural induction [30]
and the differentiation of scleraxis positive progenitors
in developing somites.
FGF/Sprouty2 signalling is a possible pathway to regulate
microRNA expression during somite myogenesis
We previously showed that FGF signalling could regu-
late somite myogenesis by controlling microRNA
expression [43,44]. FGF4 overexpression led to loss of
mir-206 indicating that it negatively regulates the initia-
tion of mir-206 gene expression [43]. In the current
study, we used Targetscan (Version 5) to identify micro-
RNAs predicted to target the 3’UTR of chick Spry2. The
analysis showed that mir-21, mir-23, mir-27, mir-122
and mir-128 can potentially interact with Spry2 through
binding to its 3’UTR (Figure 6A). We next carried out
Northern blotting of these microRNAs to check if they
are expressed in epithelial somite RNA extracts at
HH10 (1.5 Day) and HH27 (5 Day). In our hands, only
Figure 3 Spry2 gain-of-function inhibits somite myogenesis. Electroporation of pCAB-Spry2 full length or RFP-MKP3 expression constructs
into epithelial somites at HH16, as indicated, followed by 24-hour incubation to HH21/22. (A-C) Whole mount in situ hybridisation for MyoD
(purple) and GFP or RFP (red), (Ai) is a section of embryo in (A). (A, Ai) Spry2 expression led to loss of MyoD in transfected cells, arrows in (A)
indicate the targeted electroporated somites and lines indicate the level of sectioning in (Ai). (B) Electroporation of an empty pCAB-IRES-GFP
expression vector (used as a control) into somites which showed normal MyoD expression (arrows). (C) Loss of MyoD was observed in cells
electroporated with RFP-Mkp3 (arrows); (Ci) RFP detected by fluorescent filter Alexa-Fluor-465 in the same electroporated somites in (C). (D)
Control of unelectroporated embryo showing normal MyoD expression. Magnifications: 20x in (A, B, C & D), 24x in (Ci), 200x in (Ai).
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mir-23, mir-27 and mir-128 showed strong expression in
somites (Figure 6B). Together with the Targetscan ana-
lysis these results raise the possibility of the involvement
of these three microRNAs in FGF/Spry2 signalling. How-
ever, further analysis using gain- and loss-of-function of
mir-23, mir-27 and mir-128 is required to proof or to
exclude an interaction with FGF/Spry2 signalling.
Conclusions
We analysed the endogenous expression of Spry2 during
early somite myogenesis in chick and showed colocalisa-
tion of Spry2 transcripts with two early myogenic mar-
kers MyoD and Mgn. In addition, we showed for the
first time that overexpression of Spry2 results in reduc-
tion of somite myogenesis indicated by loss of MyoD
expression, and conversely interference with its function
using its C-terminal domain resulted in promoting myo-
genesis by increasing the number of the myogenic cells.
This suggests that Spry2 could regulate myogenic cell
proliferation activity in the forming somite in chick. We
also demonstrated that FGF2 induces Spry2 expression.
It is also possible that other FGF ligands in addition to
FGF2 could be tuned by Spry2 via a negative feedback
loop to regulate chick somite myogenesis including
FGF4 and FGF8. Furthermore, additional players in
Spry2/FGF negative feedback loop signalling may involve
particular microRNAs. Our analysis of Targetscan fol-
lowed by Northern blots of developing somites showed
that mir-23, mir-27 and mir-128 could be part of this
negative feedback loop mechanism.
Materials and methods
Embryo manipulations and electroporation
Fertile white Leghorn chicken eggs obtained from Henry
Stuart (Lincolnshire) were incubated at 38°C and staged
according to Hamburger and Hamilton (HH) [45]. Eggs
were windowed and black ink was injected underneath
the blastoderm to visualise the embryos. Electroporation
was carried out as described previously [46]. Briefly,
HH16 epithelial somites on one side of the embryo were
Figure 4 Spry2-Cterminus promotes somite myogenesis. pCAB-Spry2-Cterm was overexpressed in epithelial somites by electroporation
followed by harvesting embryos at different time points of incubation: (A) 6-hours, (B) 11-hours, (C, Ci) 24-hours and (D, Di) 48-hours. An
increase of MyoD expression was detected (A-Di) which was associated with an increase in the somites size after incubation of 48-hours (D, Di).
Arrows in (A, B, C & D) indicate the electroporated somites and arrowheads in (Ci, Di) indicate the electroporated myotomes and cells.
Magnifications: 20x in (A, B, C & D), 200x in (Ci, Di).
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Figure 5 Targeted misexpression of pCAB-Spry2-Cterminal results in increased number of mitotic cells in the dermomyotome and
myotome. (A-Aiii) Brightfield and fluorescent images of the electroporated control side. (B-Biii) Brightfield and fluorescent images of pCAB-Spry2-
Cterminal injected and electroporated somites. (A, B) Increased MyoD expression was detected by in situ hybridization (purple) in the injected/
electroporated side in (B) with GFP detected in red. (Ai, Bi) Sections were stained with DAPI and dermomyotome and myotome boundaries are
indicated with dotted white lines. (Aii, Bii) Immunostaining with anti-Phospho-Histone-H3 detects mitotic cells and shows an increase of the number
of the dividing cells in injected dermomyotome and myotome (Bii, within the dotted white lines) in comparison to the contralateral control somite in
(Aii). (Aiii, Biii) merged images of DAPI in (Ai, Bi) and Phospho-Histone-H3 stained sections in (Aii, Bii). Maginfications: 200x in all sections. (C). Statistical
analysis of the anti-Phospho-Histone-H3 proliferation assay for pCAB-Spry2-Cterminal. Columns represent results of the SPSS statistical analysis of the
proliferating cells in myotomes and dermomyotomes of uninjected somites (blue column, control) and in pCAB-Spry2-Cterminal electroporated
somites (red column). The analysis confirmed that the differences in the means of paired counting (n=94) of the proliferating myocyte cells were
statistically significant (p < 0.002), the diagram shows a graphical representation of these data. Error bars represent the standard deviation [48].
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injected with plasmid DNA at a concentration of 1-1.5
mg/ml. The pCAB-Spry2 full length and pCAB-Spry2-
Cterm (contains only the Spry2 C-terminal part) plasmids
were kind gifts from Professor Cornelis Weijer (University
of Dundee). RFP-MKP3 construct was described in [9].
The contralateral, non-injected side was used as a control.
Plasmids produced GFP or RFP, which allowed tracing of
successful electroporation. Positive and negative platinum
electrodes (0.3 mm diameter) were placed on either side
of the somites, 5 pulses of 20 Volts for 35 milliseconds
were applied using a TSS20 Ovodyne electroporator
(Intracel). Eggs were sealed and incubated for 24, 48 hours
or as indicated. After harvesting in DEPC/PBS, electropo-
rated embryos were checked for GFP or RFP fluorescent
signals using Leica dissecting microscope with fluorescent
filters Alexa-Fluor-488 to detect GFP or Alexa-Fluor-465
to detect RFP. Only embryos showing positive signals in
the targeted somites are processed for overnight fixation
in 4% paraformaldehyde (4°C) and subsequent in situ
hybridisation as described in [47].
Bead implantation
The method described in [9] was followed. Briefly,
Heparin beads (Sigma H-5263) were washed three times
in PBS before soaking for 1 hour at room temperature in
recombinant FGF (R&D Systems) at the following concen-
trations: FGF2 (400μg/ml) and FGF4 (50μg/ml). After
washing twice in PBS, beads were implanted adjacent to
forelimb or flank level somites of HH16 embryos. Control
beads were soaked in PBS. Embryos were allowed to
develop for 24 hours and were then analysed by whole
mount in situ hybridisation.
Probe synthesis, in situ hybridisation and immunostaining
Probes for whole mount in situ hybridisation were
synthesized as described previously: [13] for Spry2;[30]
for Mkp3; [9] for MyoD and Mgn. Single in situ hybridi-
sation was carried out as previously described [5]. Dou-
ble in situ hybridisation of Spry2 (detected in blue or
purple) and MyoD or Mgn (detected in red) was carried
out as previously described [46].
For cryosectioning, embryos were fixed in 4% PFA/
0.2% glutaraldehyde, washed with PBS, transferred to
30% sucrose/PBS and embedded in OCT. For immunos-
taining with anti-Phospho-Histone-H3 antibody (1:500,
Developmental Studies Hybridoma Bank) sections
(10 µm) were incubated with 0.1% Triton X-100 and
treated with 1:10 H2O2/PBS for 10 minutes. After wash-
ing in PBS, sections were blocked in 10% goat serum
and treated with primary antibody overnight at 4°C.
Sections were blocked in 10% goat serum before apply-
ing secondary antibody (anti-rabbit fluorescent Alexa
Fluor-488, 1:1000, Molecular Probes). Sections were
treated with DAPI to stain nuclei and mounted in
Mowiol. Pictures were taken with Axiovision software
on an Axioscope (Zeiss, Germany).
The number of Phospho-Histone-H3 positive cells was
counted in the dermomyotomes and myotomes for both
electroporated and uninjected contralateral (control)
somites. Counts from pCAB-Spry2 and pCAB-Spry2-
Cterminus injected and uninjected somites were treated
as paired readings (n=94). Statistical analysis was carried
out using SPSS to calculate means and standard errors
to confirm the significance of the observed differences
(Wilcoxon test).
Figure 6 Chick Spry2 is a predicted target of a number of microRNAs. (A). Sequence alignments show miR predicted targets sites within
the 3’UTR of chick Spry2 and chick microRNA sequences of mir-21, mir-23, mir-27, mir-122, and miR-128. Complementary nucleotides are
highlighted in red and seed sequence of each microRNA is highlighted in grey. (B) Northern blot showing expression of the microRNAs-21, -23,
-27, -122 and -128 in epithelial somites at HH10 (1.5 days) and HH27 (5-days) of chick embryo development, U6 nuclear snRNA was used as an
internal control.
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RNA extraction and Northern blotting
RNA extraction followed by Northern blotting were carried
out according to the methods described in [43]. Briefly,
epithelial somites of embryos at HH10 (1.5 day) and HH27
(5 day) were dissected and washed in PBS and then trans-
ferred to lysis buffer containing guanidinum thiocyanate.
Chloroform/isoamyl alcohol purification was carried out
and RNA was precipitated in ethanol. For Northern blot-
ting, 50 μg of total RNA was separated on 15% denaturat-
ing polyacrylamide gel electrophoresis (PAGE), stained
with ethidium bromide/MOPS for 10 min and then visua-
lized by UV trans-illuminator. RNA was transferred to five
membranes (Hybond NX, Amersham Biosciences) then
hybridized to 32P-labeled antisense probes (end-labelled
with [g-32P]ATP and T4 kinase) complementary to the
mature mirRNA of gga-miR-21, gga-miR-23, gga-miR-27,
gga-miR-122 and gga-miR-128 that cover the entire length
of the miRNAs. Hybridization was carried out using EDC
carbodiimide in 12.5 M 1-methylimidazole. Blots were pre-
hybridised in UltraHyb Oligo (Ambion) and hybridised
overnight at 37°C in a hybridisation oven. Membranes
were washed twice for 30 min and then exposed at room
temperature to Fuji Bass cassette 2040 (Fuji). Next, the
membranes were stripped and hybridised with probe
detecting the U6 small nuclear RNA as a control.
RNA extraction followed by Northern blotting were car-
ried out according to the methods described in [43].
Briefly, epithelial somites of embryos at HH10 (1.5 day)
and HH27 (5 day) were dissected and washed in PBS and
then transferred to lysis buffer containing guanidinum
thiocyanate. Chloroform/isoamyl alcohol purification was
carried out and RNA was precipitated in ethanol. For
Northern blotting, 50 μg of total RNA was separated on
15% denaturating polyacrylamide gel electrophoresis
(PAGE), stained with ethidium bromide/MOPS for 10 min
and then visualized by UV trans-illuminator. RNA was
transferred to five membranes (Hybond NX, Amersham
Biosciences) then hybridized to 32P-labeled antisense
probes (end-labelled with [g-32P]ATP and T4 kinase) com-
plementary to the mature mirRNA of gga-miR-21,
gga-miR-23, gga-miR-27, gga-miR-122 and gga-miR-128
that cover the entire length of the miRNAs. Hybridization
was carried out using EDC carbodiimide in 12.5 M
1-methylimidazole. Blots were pre-hybridised in UltraHyb
Oligo (Ambion) and hybridised overnight at 37°C in a
hybridisation oven. Membranes were washed twice for 30
min and then exposed at room temperature to Fuji Bass
cassette 2040 (Fuji). Next, the membranes were stripped
and hybridised with probe detecting the U6 small nuclear
RNA as a control.
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Additional material
Additional file 1: Figure S1. Spry2 expression at HH24 of chick
embryo. (A) Whole mount in situ hybridisation showing Spry2 expression
in somites, fore- and hindlimbs. (B) Transverse section at the level of the
hindlimb bud showing Spry2 strongly expressed in dorsal and ventral
limb bud muscle masses. Magnifications: 22x in (A), 100x in (Ai).
Additional file 2: Figure S2. Expression of Spry2 in somites and limb
buds is closely associated with Mgn. (A) Whole mount double in situ
hybridisation of chick embryo at HH24 showing Spry2 expression (in
purple) combined with that of Mgn (in red) in somites and limb buds.
(Ai) Transverse section at the level of forelimb bud showing Spry2
expression overlapping with that of Mgn throughout the myotome and
limb bud. (Aii) Transvers section through a myotome showing Spry2 and
Mgn overlapped expression. (Aiii) Frontal sections showing Spry2/Mgn
expression in the myotomes. Magnifications: 18x in (A), 50x in (Ai), 200x
in (Aii), 100x in (Aiii).
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